Bayer targets 9.6% gain in 2020 adjusted EBITDA

LEVERKUSEN, Germany (Reuters) - Germany's Bayer said on Thursday it was targeting growth in adjusted core profit of up to 9.6% this year, driven by sales of agriculture products and pharmaceuticals.Bayer, which is fighting costly lawsuits over claims its glyphosate-based weedkillers cause cancer, laid out a goal for earnings before interest, taxes, depreciation and amortisation (EBITDA) adjusted for special items and currency swings to reach 12.3-12.6 billion euros (10.4-10.6 billion pounds),..